focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Goldman*
So you have a link regarding Goodman’s transactions in the stock?
Finally closed above 1800. Although market markers keep tanking the price in the last 5 mins of the day.
INDV is the US ticker symbol.
The NASDAQ share is still trading at a premium to the UK one if you convert currencies. So US still needs to drop or UK needs to go up so the spread between the two is minimal.
My guess is not much until first official earnings after the listing? So July/August?
I think Norway is where he wants to focus.
3 months worth of losses almost recovered in 3 days.
ShearClass, xtw2, mythaar, are you guys on any other platforms like twitter? Would be nice to get a group chat going with fellow shareholders. I'm in a telegram group for another UK stock I'm in (Kistos).
Value Investors Club discussion on INDV stock.
“ This settlement is only for a portion of the potential liability. The MDL covers the states (41 states and DC), direct purchasers (distributors), and end payors (insurance companies). Therefore, this $102.5m settlement only covers the first of the three potential liabilities.
Despite not being a full resolution of the MDL, we believe this is positive as INDV lost almost $1bn of market cap following the announcement of the MDL provision. The $102.5m which is being described as "in line" with the initial provision should give investors some confidence that the ultimate settlement amount will not exceed the $290m provision. This is important because part of the overreaction was when management stated that the settlement amount "could ultimately be higher or lower". Assuming they settle for $290m, INDV should recover a substantial portion of the loses incurred after they announced Q4 earnings.
INDV is most likely trying to settle all of these liabilities before officially listing in the US (June 12th), so there could be further announcements this week. “
That is fascinating. Aren't the generics supposed to literally be identical to Suboxone?? How are they causing issues lol
Not to mention revenue growth next year from OPVEE.
The only big ? is how much Suboxone revenue we will see going forward. Right now, market share has been stable. But a 4th generic enters the market later this year...will it make a difference? Maybe not.
Where can I listen to this? Is there a transcript?
“Great news and at the last presentation, they were strongly hinting that they were progressing well with the mediation to settle.”
Was this from the commentary? I didn’t see anything in the slides that particularly hinted at this
This is excellent news. They settled for about 1/3 of the charge they took.
Wait no, I read that wrong!!
It’s only $102 million??
Https://otp.tools.investis.com/clients/uk/indivior2/rns/regulatory-story.aspx?cid=971&newsid=1692361
Looks like it’s the $290 million charge they originally reserved against.
Stock is still yawning here. I wonder what the catalyst is here. Hopefully the NASDAQ listing drives some buying.
FYI, Dutch taxes don't apply below 47 euro TTF.